BiotechTube
Home/Ochre Bio/Jack Castle
JC

Jack Castle

Chief Business Officer

Ochre Bio

Therapeutic Areas

Chronic Liver DiseaseLiver FibrosisCirrhosisMASH/MASLD

Ochre Bio Pipeline

DrugIndicationPhase
OB-220Significant FibrosisPreclinical
Undisclosed Metabolic ProgramCirrhosis (F4 MASH)Preclinical
Undisclosed Multiple Mechanism ProgramSignificant FibrosisDiscovery
Undisclosed Regeneration ProgramCirrhosisDiscovery

Leadership Team at Ochre Bio

QW
Quin Wills
Founder & CEO
EF
Eliot Forster, PhD
Board Chair
SB
Sarah Batey
Chief Operating Officer
CU
Chinwe Ukomadu, MD, PhD
Board Observer
View full Ochre Bio profile